EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Costunolide ameliorates autoimmune uveitis by targeting USP15 to suppress TNF-α-induced retinal endothelial inflammation

Yu Gao iD, Xingran Li, Lingyu Dai, Xiang Luo, Guannan Su, Kai Shi, Ling Chen iD, Peizeng Yang

Proceedings of the National Academy of Sciences · 14.07.2026 · 123 (28)

DOI: 10.1073/pnas.2533845123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 07.07.2026. Verfasst von Yu Gao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology Medical Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory for the Prevention and Treatmen…. Hauptthemen laut MEDLINE: Uveitis, Tumor Necrosis Factor-alpha, Autoimmune Diseases, Sesquiterpenes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation Key Program, Chongqing Outstanding Scientists Project, Chongqing Chief Medical Scientist Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmune uveitis is a sight-threatening inflammatory disease, with the majority of entities driven by leukocyte infiltration into the retina. A critical early step in this process is the activation of retinal vascular endothelial cells (ECs), which up-regulate adhesion molecules that mediate T cell adhesion and subsequent extravasation. Here, we identify the small terpenoid compound costunolide (COS) as a potent suppressor of retinal endothelial inflammation and disease progression in experimental autoimmune uveitis (EAU). Quantitative proteomics of primary human retinal endothelial cells stimulated with TNF-α defined a proinflammatory endothelial signature and revealed induction of adhesion molecules. Screening of a focused library of 337 terpenoids uncovered COS as a top hit that markedly attenuated TNF-α-induced endothelial activation. In vivo, COS treatment significantly reduced clinical and histopathologic EAU scores, accompanied with reduced endothelial adhesion molecule expression and decreased T cell infiltration. Mechanistically, COS directly targeted deubiquitinase USP15, inhibiting USP15-dependent deubiquitination of TRAF1 and TNF signaling in retinal ECs. These findings establish COS as a candidate therapeutic agent for autoimmune uveitis and reveal a TNF-α–USP15–TRAF1 axis in retinal endothelium that can be pharmacologically exploited to limit pathogenic leukocyte trafficking.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UveitisTumor Necrosis Factor-alphaAutoimmune DiseasesSesquiterpenesAnimalsHumansEndothelial CellsMiceUbiquitin ThiolesteraseInflammationRetina

Stichwörter der Autor:innen

TNF-αUSP15costunolideretinal endotheliauveitis

Substanzen

Tumor Necrosis Factor-alphaUbiquitin ThiolesteraseSesquiterpenes

Autor:innen und Institutionen

  • Ophthalmology Medical Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory for the Prevention and Treatment of Major Blinding Eye Diseases, Chongqing Branch (Municipality Divis…
  • Eye Institute and Department of Ophthalmology, Eye and ENT Hospital, Fudan University, Shanghai 200031, China.

ORCID-Profile: Yu Gao, Ling Chen

Förderung

  • National Natural Science Foundation Key Program
  • Chongqing Outstanding Scientists Project
  • Chongqing Chief Medical Scientist Project
  • Chongqing Science and Technology Bureau Mountaineering Project
  • Science and Technology Cooperation Project of the First Affiliated Hospital of Zhengzhou University (institution) 2025Hx39 (award-id) Peizeng Yang (principal-a…

Zitieren

APA

Gao, Y., Li, X., Dai, L., Luo, X., Su, G., Shi, K., Chen, L., & Yang, P. (2026). Costunolide ameliorates autoimmune uveitis by targeting USP15 to suppress TNF-α-induced retinal endothelial inflammation. Proceedings of the National Academy of Sciences, 123(28). https://doi.org/10.1073/pnas.2533845123

Vancouver

Gao Y, Li X, Dai L, Luo X, Su G, Shi K, et al. Costunolide ameliorates autoimmune uveitis by targeting USP15 to suppress TNF-α-induced retinal endothelial inflammation. Proceedings of the National Academy of Sciences. 2026;123(28). doi:10.1073/pnas.2533845123

BibTeX
@article{Gao2026,
  author = {Gao, Yu and Li, Xingran and Dai, Lingyu and Luo, Xiang and Su, Guannan and Shi, Kai and Chen, Ling and Yang, Peizeng},
  title = {Costunolide ameliorates autoimmune uveitis by targeting USP15 to suppress TNF-α-induced retinal endothelial inflammation},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {28},
  doi = {10.1073/pnas.2533845123}
}
Kostenlos starten →